| Dose/day | Cmax (ng/ml) | Cmin (ng/ml) | |
| Bosutinib | Probably does not require monitoring | ||
| Dasatinib | 100 mg/day (QD) | >50 (efficacy) | <2.5 (tolerance) |
| Imatinib | 400 mg/day (QD) | >1000 (efficacy) >3000 (tolerance) | |
| Nilotinib | 600 mg/day (BID) | 800 (efficacy) | |
| Ponatinib | No information | ||